CHICAGO, May 24, 2021 /PRNewswire/ — According to the new market research report “Neurovascular Devices/Interventional Neurology Market by Product (Embolization(Coil, Flow Diverter), Stents, Balloon Occlusion Devices, Clot Retrievers, Microcatheters), Pathology (Stroke, Aneurysm, CAS, AVM) User (Hospital, ASC) – Global Forecasts to 2026″, published by MarketsandMarkets™, the global Neurovascular Devices Market is expected to grow from an estimated USD 2.5 billion in 2021 to USD 3.8 billion by 2026, at a CAGR of 8.6%.
Browse in-depth TOC on “Neurovascular Devices Market”
261 – Tables
49 – Figures
281 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=847
The growing target patient population, ongoing product development, and commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across the emerging markets, growth in market demand for effective neurovascular devices, increase in research in the field of neurovascular therapies, rise in demand for minimally invasive neurosurgical procedures, and increase in awareness among neurosurgeons about minimally invasive surgical procedures are high growth prospects for the neurovascular devices/ interventional neurology market during the forecast period.
The aneurysm coiling & embolization devices segment is expected account for the largest share of the market during the forecast period.
On the basis of product, the neurovascular devices market is…
